Search details
1.
Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
Annu Rev Genomics Hum Genet
; 23: 449-473, 2022 08 31.
Article
in English
| MEDLINE | ID: mdl-35537468
2.
Incorporating G6PD genotyping to identify patients with G6PD deficiency.
Pharmacogenet Genomics
; 32(3): 87-93, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-34693927
3.
Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy.
Haematologica
; 107(2): 371-380, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34196166
4.
Dasatinib does not exacerbate dexamethasone-induced osteonecrosis in murine models of acute lymphoblastic leukemia therapy.
Pediatr Blood Cancer
; 69(4): e29490, 2022 04.
Article
in English
| MEDLINE | ID: mdl-34866312
5.
Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies.
Cancer
; 127(12): 2074-2082, 2021 06 15.
Article
in English
| MEDLINE | ID: mdl-33598942
6.
Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia.
Cancer
; 126(21): 4800-4805, 2020 11 01.
Article
in English
| MEDLINE | ID: mdl-32809242
7.
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(1): e28040, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31612640
8.
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Annu Rev Pharmacol Toxicol
; 55: 89-106, 2015.
Article
in English
| MEDLINE | ID: mdl-25292429
9.
Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Antimicrob Agents Chemother
; 62(8)2018 08.
Article
in English
| MEDLINE | ID: mdl-29866879
10.
CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpoints.
BMC Bioinformatics
; 17(Suppl 13): 382, 2016 Oct 06.
Article
in English
| MEDLINE | ID: mdl-27766934
11.
6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study.
Blood
; 124(15): 2345-53, 2014 Oct 09.
Article
in English
| MEDLINE | ID: mdl-24829202
12.
Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determination.
Genet Med
; 22(1): 232-233, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31341243
13.
Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.
Blood
; 121(21): 4366-76, 2013 May 23.
Article
in English
| MEDLINE | ID: mdl-23538338
14.
Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
Pediatr Blood Cancer
; 62(9): 1518-22, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25631103
15.
Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
JAMA
; 313(8): 815-23, 2015 Feb 24.
Article
in English
| MEDLINE | ID: mdl-25710658
16.
PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
Am J Med Genet C Semin Med Genet
; 166C(1): 45-55, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24619595
17.
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.
Hum Mol Genet
; 21(21): 4793-804, 2012 Nov 01.
Article
in English
| MEDLINE | ID: mdl-22846425
18.
Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib.
Haematologica
; 104(5): e218-e221, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30819904
19.
Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma.
Pediatr Blood Cancer
; 61(2): 373-5, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-23955991
20.
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment.
Nat Commun
; 15(1): 3681, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38693155